ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
Globe Newswire•05/08/2026•16:05 ET
0
Whiz Insights
2Q 2026 Total Revenue of $124.4 Million, Increasing 2% Year-over-Year
2Q 2026 ASCENIV Revenue of $102.9 Million, Increasing 24% Year-over-Year
Get started
Create a free account to read the full story.